Gossamer Bio, Inc. — Director's Dealing 2019

Feb 8, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Gossamer Bio, Inc. (GOSS)
CIK: 0001728117
Period of Report: 2019-02-07

Reporting Person: GALA RENEE D (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$10.71	2028-12-14	Common Stock (46666)		Direct

Footnotes

F1: 1/36th of the total number of shares subject to the option vested on January 14, 2019 and 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date.